Application of autoantibody detection in chronic liver disease
iLABMED · 2023
DOI: 10.1002/ila2.18 ↗Kurz gefasst
Fachartikel in der Zeitschrift iLABMED, 2023. Verfasst von Jinyu Han und 2 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Autoantibody (AAb) detection has become one of the standards of diagnosis for autoimmune liver disease (AILD), and some AAbs have become specific biomarkers of AILD. In addition, AAbs can be detected in patients with non‐AILDs, such as viral hepatitis and alcoholic liver disease. However, the distribution characteristics and pathogenic mechanisms of AAbs in patients with non‐AILD are unclear. This article summarizes the characteristics of AAbs in several common clinical chronic liver diseases (CLDs) and discusses the value of AAb analysis in CLD.
Zitieren
APA
Han, J., Chen, J., & Wang, Y. (2023). Application of autoantibody detection in chronic liver disease. iLABMED. https://doi.org/10.1002/ila2.18
Vancouver
Han J, Chen J, Wang Y. Application of autoantibody detection in chronic liver disease. iLABMED. 2023. doi:10.1002/ila2.18
BibTeX
@article{Han2023,
author = {Han, Jinyu and Chen, Jin and Wang, Yajie},
title = {Application of autoantibody detection in chronic liver disease},
journal = {iLABMED},
year = {2023},
doi = {10.1002/ila2.18}
}
EUVIMED